What did @wellnessbyhaleigh actually say?
The video is a casual, first-person walkthrough of a weekly GLP-1 injection routine. She says she doses in her stomach, uses an alcohol pad to prep, does her shot on Sundays, and takes it "right before I go to bed" so she can "sleep through the night." She also mentions she never gets bad side effects and that her current focus has shifted to building muscle and eating more protein now that she's lost weight.
The caption (which appears to be cut off) adds two structured tips: keeping a consistent weekly injection time for side effect management, and rotating injection sites between the stomach, thigh, and back of the arm to avoid irritation. The spoken content is anecdotal. The written caption leans more instructional. That distinction matters when you're evaluating what's actually being communicated to 74,000-plus viewers.
Does the science back this up?
On the core practices, yes, mostly. Site rotation and consistent weekly timing are both grounded in real pharmacology. Semaglutide has a half-life of approximately seven days, which is precisely why once-weekly dosing works, and inconsistent timing can create variability in plasma concentration. The bedtime dosing angle is less studied but not unreasonable.
Semaglutide's half-life of around 165-184 hours (Kapitza et al., 2015, Clinical Pharmacokinetics) means timing precision matters less than it does for, say, a daily medication. But consistent dosing windows help patients build reliable habits, which itself reduces missed doses. The injection site rotation advice is supported by subcutaneous injection best practices for insulin and analogous drugs. The FDA-approved prescribing information for Wegovy specifies rotating sites to reduce localized lipohypertrophy. The bedtime claim, that you can "sleep through" nausea, is not directly tested in clinical trials but aligns loosely with anecdotal reports in patient communities and the known timing of peak GLP-1 receptor activity.
What did they get wrong (or right)?
She got the fundamentals right. Alcohol wipe before injection, site rotation, consistent weekly timing: these are standard, appropriate practices. Credit where it's due.
What's missing is more concerning than what's wrong. Saying "shot days are always so easy, it's nothing to worry about" is not universally true, and broadcasting that to tens of thousands of people starting their first injection is potentially misleading. Clinical trial data for semaglutide (STEP 1 trial, Wilding et al., 2021, New England Journal of Medicine) shows that nausea affected 44% of participants and vomiting affected 25%. Telling a broad audience that side effects are essentially a non-issue because of personal experience undersells the real landscape of what new patients may encounter. Her experience is valid. Her experience is not the norm. There is also no mention of proper needle disposal, which is a public health issue, not a nitpick. Sharps waste from GLP-1 injections is regulated in most U.S. states.
What should you actually know?
Three things matter here if you're a GLP-1 patient watching content like this.
First, consistent weekly timing is genuinely useful, but the reason is habit formation and steady-state plasma levels, not some kind of weekly absorption window. The phrase "this entire week to really absorb everything" is vague in a way that could be misread as pharmacologically meaningful. The drug's half-life manages that automatically.
Second, bedtime dosing is a reasonable strategy for some people. A small patient-reported survey published in Obesity Medicine (Wharton et al., 2021) noted that timing adjustments were a common self-management strategy for GI side effects. But it is not a guaranteed fix, and if you're experiencing significant nausea or vomiting, that warrants a conversation with your prescriber, not a TikTok workaround.
Third, injection technique matters beyond just wiping with alcohol. Pinching the skin, injecting at the correct angle, and not rubbing the site afterward are all part of proper subcutaneous technique. None of this appeared in the video. For a platform giving injection advice to a large audience, that's a meaningful gap.
Bottom line
This video is well-intentioned and the core advice is not wrong. But anecdotal experience shared at scale becomes de facto medical guidance, and the "nothing to worry about" framing around side effects does a disservice to the significant percentage of patients who do struggle, especially in the early titration phase. Personal testimonials are not clinical data, and the two should not be conflated.